OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of #cancer.
Looking for a particular OnKure Therapeutics employee's phone or email?
The OnKure Therapeutics annual revenue was $9.9 million in 2026.
Dylan Hartley is the Chief Scientific Officer of OnKure Therapeutics.
40 people are employed at OnKure Therapeutics.
OnKure Therapeutics is based in Boulder, Colorado.
The NAICS codes for OnKure Therapeutics are [5417, 54, 54171, 541, 541714].
The SIC codes for OnKure Therapeutics are [283, 87, 28].